Nexavar drug is found to improve survival rates in liver cancer patients.
A joint team of researchers from Hospital Clinic of Barcelona and Barcelona Clinic Liver Cancer (BCLC) Group has examined 602 advanced liver cancer patients who were divided into two groups: one group was taking Nexavar – sorafenib, the second group was taking a placebo.
Placebo [...]
Nexavar becomes the latest and newest approved treatment for liver cancer in China. Nexavar is made by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals and received approval by China’s State Food and Drug Administration (SFDA) for liver cancer treatment.
Nexavar (sorafenib) is the first and the only approved pill for unresectable or metastatic hepatocellular carcinoma, which are [...]
Infection with hepatitis B virus (HBV) causes liver cancer in some individuals, but not all strains of the virus are associated with the same degree of risk. If confirmed, the newly reported data could help target chemoprevention strategies in the future.
Researchers have previously identified eight genotypes of HBV and a variety of mutations in [...]
Patients with liver cancer can become viable candidates for transplantation if their tumors respond to treatment, a new study suggests. This report is in the September issue of Hepatology, a journal published by John Wiley %26amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is available online [...]
Researchers are poised to unlock the genetic secrets stored in hundreds of thousands of cancer biopsy samples that are in long-term storage and previously thought to be useless for modern genetic research. With the aid of a new technique developed by Howard Hughes Medical Institute researchers, scientists can now reconstruct thousands of genes that are [...]
New research shows how a particular small molecule blocks the activity of a cancer-suppressing gene, allowing liver-cancer cells to grow and spread.
This molecule is a microRNA, a recently discovered class of tiny molecules used by cells to help control the kinds and amounts of proteins they make. More than 250 different microRNAs have been discovered, [...]
Progen Pharmaceuticals awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence the Phase 3 program as rapidly as possible, the Company will no longer continue with the Special Protocol Assessment process.
The Company has used the Special Protocol Assessment (SPA) process to obtain valuable [...]
Nexavar becomes the first FDA-approved drug treatment therapy for patients suffering from liver cancer. Nexavar is made by Bayer Healthcare and the FDA liver cancer treatment node was announced today.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application for Nexavar [...]
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver, researchers report.
“Patients with this type of liver cancer have a very poor prognosis and the only currently available therapy is sorafenib. This study shows that we may be able to effectively use [...]
Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver, researchers report.
%26quot;Patients with this type of liver cancer have a very poor prognosis and the only currently available therapy is sorafenib. This study shows that we may be able to effectively use [...]